Overzicht Proefschriften
Tips in using the search/filter fieldsGo to page:
- of 6
- >
Displaying 1-50 of 278 results.
Titel | Promovendus | Promotor 1 | Promotor 2 | Copromotor 1 | Copromotor 2 | Universiteit | Promotiejaar | Trefwoorden |
---|---|---|---|---|---|---|---|---|
Treatment response in childhood asthma | Vijverberg S.J.H., PhD | Raaijmakers J.A.M., prof. dr. | Maitland-van der Zee A.H., prof. dr. | Universiteit Utrecht (UU) | 2014 | Treatment outcomes; Children; Asthma; | ||
Methodological approaches to the pharmacogenomics of statins | Peters B.J.M., dr. | Boer A. de, prof. dr. | Maitland-van der Zee A.H., prof. dr. | Klungel O.H., prof. dr. | Universiteit Utrecht (UU) | 2010 | Methodology; Statins; Pharmacogenomics; | |
Towards better treatment outcomes in childhood asthma | Koster E.S., PhD | Raaijmakers J.A.M., prof. dr. | Maitland-van der Zee A.H., prof. dr. | Universiteit Utrecht (UU) | 2011 | Asthma; Children; Treatment Outcomes; Epidemiology; | ||
Angiotensin II-induced vasodilation: role of bradykinin, NO and endothelium-derived hyperpolarizing factors | Batenburg W.W., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2005 | Cardiovascular disease; Pharmacology; | |||
Cardiac aldosterone: origin and effects | Chai W., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2005 | Cardiovascular disease; Pharmacology; | |||
Vascular pharmacology of migraine and preeclampsia: Problems of the fair sex | Gupta S., dr. | Saxena P.R., prof. dr. | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2006 | Cardiovascular disease; Pharmacology; | |
Characterization of vascular 5-hydroxytryptamine, adrenergic and CGRP receptors in relation to migraine | Mehrotra S., dr. | Saxena P.R., prof. dr. | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2006 | Cardiovascular disease; Pharmacology; | |
Unraveling the complexities of the renin-angiotensin system: from ACE to renin inhibition | Esch J.H.M. van, dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2008 | Cardiovascular disease; Pharmacology; Renin-angiotensin system; | |||
(Pro)renin revisited: new insights from studies in mast cells | Krop M., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2009 | Cardiovascular disease; Pharmacology; Prorenin; | |||
Natriuretic peptides, diagnostics and prognostic biomarkers | Rutte J.H.W., dr. | Danser A.H.J., prof. dr. | Meiracker A.H. van den, dr. | Erasmus Universiteit Rotterdam (EUR) | 2010 | Antihypertensive drugs; Pharmacology; Kidney; Natriuretic peptides; Renine-angiotensine system; | ||
Neurovascular pharmacology of prospective antimigraine drugs | Chan K.Y., PhD | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Migraine; Neurovascular pharmacology; | ||
Aortic pathology and the role of the renin-angiotensin system | Molzer E., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Cardiovascular disease; Renin-angiotensin system; | |||
The more complex renin-angiotensin system: new insights into an old system | Gembardt F., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Renin-angiotensin system; | |||
Cardiovascular, renal and thyroid toxicity during angiogenesis inhibition: a translational approach | Kappers M.H.W., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Cancer; Pharmacology; Antihypertensive drugs; | |||
Vascular aging from DNA damage to protection | Ďurik M., PhD | Danser A.H.J., prof. dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2012 | Cardiovascular disease; Pharmacology; | ||
The role of aldosterone and aldosterone blockade in hypertension | Jansen P.M., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2013 | Cardiovascular disease; Antihypertensive drugs; Pharmacology; | |||
Neurovascular pharmacology of migraine: epigenetics and sex hormones | Labruijere S., PhD | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2014 | Pharmacology; Migraine; Epigenetics; Neurovascular pharmacology; | ||
Novel directions in therapy against age-related vascular disease | Wu H., PhD | Danser A.H.J., prof. dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2014 | Pharmacology; Cardiovascular disease; | ||
The alternative renin-angiotensin system: exploration of its therapeutic potential | Sevá Pessôa B., PhD | Danser A.H.J., prof. dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2015 | Pharmacology; Cardiovascular disease; Renin-angiotensin system; | ||
The (pro)renin receptor: moving away from prorenin? | Lu X., PhD | Danser A.H.J., prof. dr. | Meima M.E., dr. | Erasmus Universiteit Rotterdam (EUR) | 2014 | Cardiovascular disease; Pharmacology; Prorenin; | ||
Preeclampsia, the renin-angiotensin-aldosterone system and beyond | Verdonk K., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2015 | Pre-eclampsia; Antihypertensive drugs; Pharmacology; Primary care; Renin-angiotensin system; | |||
Driving-impairing medicines and traffic safety: patients' perspectives | Monteiro S.P., PhD | Gier J.J. de, prof. dr. | Dijk C.E.M.J. van, dr. ir. | Rijksuniversiteit Groningen (RUG) | 2014 | |||
Improving the physical health of people with severe mental illness : the need for tailor made care and uniform evaluation of interventions | Hasselt F.M. van, PhD | Loonen A.J.M., prof. dr. | Oud M.J.T., dr. | Krabbe P.F.M., dr. | Rijksuniversiteit Groningen (RUG) | 2013 | ||
The therapeutic potential of Indoleamine 2.3-dioxygenase in kidney transplantation | Vavrinacova-Yaghi D., PhD | Henning R.H., prof. dr. | Sandovici M., dr. | Seelen M.A.J., dr. | Rijksuniversiteit Groningen (RUG) | 2014 | Pharmacology; kidney transplantation Indoleamine 2.3-dioxygenase | |
Cognition in Huntington's disease : the influence of motor behaviour and time | Hart E.P. 't, PhD | Roos R.A.C., prof. dr. | Universiteit Leiden (UL) | 2013 | Huntington's disease; Cognition; Movement disorder; Executive functioning; Memory; P300; Motor behaviour | |||
HIV treatment: a clinical pharmacology perspective | Luin M. van, dr. | Hekster Y.A., prof. dr. | Burger D.M., prof. dr. | Richter C., dr. | Radboud Universiteit (RU) | 2010 | Clinical pharmacology; Pharmacokinetics; HIV; Therapeutic drug monitoring; drug-drug interactions; antiretroviral drugs | |
Optmizing long-term care for hiv-infected patients in Thailand | Ramautarsing R.A., PhD | Burger D.M., prof. dr. | Wit F.W.N.M., dr. | Wijgert J.H.H.M. van de, dr. | Universiteit van Amsterdam (UvA) | 2013 | HIV; clinical pharmacology | |
Optimizing protease inhibitor-based antiretroviral therapy for HIV-1 infected Thai adults and children | Lugt J. van der, dr. | Lange J.M.A., prof. dr. | Ananworanich J., dr. | Burger D.M., prof. dr. | Universiteit van Amsterdam (UvA) | 2010 | Antiretroviral; HIV; Pharmacokinetics; Clinical pharmacology; therapeutic drug monitoring | |
Clinical pharmacological studies in tuberculosis patients | Semvua H.H., PhD | Burger D.M., prof. dr. | Aarnoutse R.E., dr. | Boeree M.J., dr. | Radboud Universiteit (RU) | 2014 | Clinical pharmacology; Pharmacokinetics; Tuberculosis | |
The role of efflux and influx transporters in the disposition of digitalis-like compounds | Gozalpour E., PhD | Russel F.G.M., prof. dr. | Radboud Universiteit (RU) | 2015 | ||||
The many faces of Na+, K+-ATPase: understanding the role of human isoforms in health and disease | Weigand K.M., PhD | Russel F.G.M., prof. dr. | Radboud Universiteit (RU) | 2015 | ||||
Loss of proteostasis as a substrate for Atrial Fibrilation. | Meijering R.A.M., PhD | Henning R.H., prof. dr. | Brundel B.J.J.M., dr. | Rijksuniversiteit Groningen (RUG) | 2014 | Atrial fibrillation; Proteostasis; | ||
Optimizing cancer therapy. A focus on molecular imaging | Gaykema S.B.M., PhD | Vries E.G.E. de, prof. dr. | Lub-de Hooge M.N., dr. | Rijksuniversiteit Groningen (RUG) | 2014 | |||
Preclinical targeting of the tumor microenvironment. Possibilities and consequences | Arjaans M., PhD | Vries E.G.E. de, prof. dr. | Schröder C.P., dr. | Timmer-Bosscha H., dr. | Rijksuniversiteit Groningen (RUG) | 2015 | ||
The role of endogenous H2S production during hybernation and forced hypothermia: towards safe cooling and rewarming in clinical practice | Dugbartey G.J., PhD | Henning R.H., prof. dr. | Bouma H.R., PhD | Rijksuniversiteit Groningen (RUG) | 2015 | |||
Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillation | Wiersma M., PhD | Henning R.H., prof. dr. | Brundel B.J.J.M., dr. | Rijksuniversiteit Groningen (RUG) | 2016 | Atrial fibrillation; | ||
End-organ damage in diabetes: exploring innovative targets and therapies | Hamidi M., PhD | Henning R.H., prof. dr. | Buikema J.H., dr. | Deelman L.E., dr. | Rijksuniversiteit Groningen (RUG) | 2015 | Diabetes mellitus; | |
Biomarkers as assessment of drug efficacy in cardiovascular disease | Smink P.A., PhD | Zeeuw D. de, prof. dr. | Lambers Heerspink H.J., prof. dr. | Bakker S.J.L., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2013 | cardiovascular disease biomarkers drug efficacy | |
Novel protective approaches in ischemia-reperfusion injury. In vivo studies in animals and humans | Wever K.E., PhD | Rongen G.A., prof. dr. | Masereeuw R., prof. dr. | Warlé M.C., dr. | Radboud Universiteit (RU) | 2012 | Renal, ischemia/reperfusion injury, remote ischemic preconditioning, Annexin A5, animal and human research | |
Risk factors and treatment of paediatric chronic diseases - Type 1 diabetes, asthma and allergy | Ahmadizar F., PhD | Boer A. de, prof. dr. | Maitland-van der Zee A.H., prof. dr. | Universiteit Utrecht (UU) | 2016 | Children; Diabetes mellitus; Allergy | ||
Intranasal drug delivery in migraine | Kuy P.H.M. van der, dr. | Merkus F.W.H.M., prof. dr. | Lohman J.J.H.M., dr. | Universiteit Leiden (UL) | 2003 | Migraine; Intranasal | ||
COMPARE: Care in Oncolytic Medication surveillance:Pharmacovigilance, Acceptability, Risks and Events | Oijen B.P.C. van, dr. | Schouten H.C., prof. dr. | Kuy P.H.M. van der, dr. | Janknegt R., PharmD PhD | Universiteit Maastricht (UM) | 2015 | Chemotherapy; Clinical pharmacology; Pharmaceutical care; | |
Medication surveillance in older patients : clinical decision support as the next step in medication safety | Hurkens K.P.M.G., MD PhD MBA | Stehouwer C.D.A., prof. dr. | Kuy P.H.M. van der, dr. | Janknegt R., PharmD PhD | Universiteit Maastricht (UM) | 2013 | Clinical pharmacology; Elderly; clinical rules | |
Medication Optimization; exploring the use of a clinical decision support system | Wit H.A.J.M. de, PhD | Schols J.M.G.A., prof. dr. | Kuy P.H.M. van der, dr. | Janknegt R., PharmD PhD | Universiteit Maastricht (UM) | 2016 | Clinical pharmacology; Clinical rules; CDSS | |
Exposure to antiretroviral agents in hiv-infected pregnant women: not too much-not too little | Colbers E.P.H., PhD | Burger D.M., prof. dr. | Radboud Universiteit (RU) | 2015 | HIV; antiretroviral agents; clinical pharmacology; drug drug interactions | |||
Pharmaceutical development, preclinical research and clinical application of the bone-targeting therapeutic radiopharmaceutical rhenium-188-HEDP | Lange R., PhD | Hendrikse N.H., prof. dr. | Heine R. ter, dr. | Bloemendal H.J., dr. | Vrije Universiteit Amsterdam (VU) | 2017 | Radiopharmaceutics; Pharmaceutical development; Rhenium; | |
Unintended effects of anti-hyperglycaemic drugs studied in population-based cohorts | Driessen J.H.M., PhD | Bergh J.P.W. van den, prof. dr. | Vries F. de, prof. dr. | Onzenoort H.A.W. van, PhD | Universiteit Maastricht (UM) | 2017 | Hyperglycaemic drugs; Population-based; | |
Making things easier: how to improve antiviral drug treatment for children | Bastiaans D.E.T., dr. | Burger D.M., prof. dr. | Radboud Universiteit (RU) | 2016 | Clinical pharmacology; Antiviral drug treatment; | |||
Thermopharmacology of anticonvulsive treatment after perinatal asphyxia | Broek M.P.H. van den, PhD | Egberts A.C.G., prof. dr. | Rademaker C.M.A., dr. | Universiteit Utrecht (UU) | 2013 | PK-PD modelling; Newborns; Thermopharmacology; Convulsions; | ||
Pharmacokinetics, pharmacodynamics and safety of different propofol formulations | Knibbe C.A.J., prof. dr. | Danhof M., prof. dr. | Aarts L.P.H.J., prof. dr. | Kuks P.F.M., dr. | Universiteit Leiden (UL) | 2002 | Pharmacokinetics; Pharmacodynamics; Propofol; |
Go to page:
- of 6
- >